Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Trisomy 18 Syndrome

ClinicalTrials.gov lists 27 trials for Trisomy 18 Syndrome or a narrower condition beneath it. Natera, Inc. has the most among industry and government lead sponsors, with 8.

MeSH D000073842 Cardiovascular Diseases C14 C16
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Not applicable Not applicable 2 Observational Observational 25 Not applicable Not applicable 2 Observational Observational 25

Trials per phase

27 of the 27 trials are tagged with Trisomy 18 Syndrome itself; the rest are tagged with a narrower condition beneath it.

Get the Trisomy 18 Syndrome report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Trisomy 18 Syndrome trials start? (14)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Not applicable
  • Observational

Top of scale: 4

2008: 1 trials (Observational 1) 2009: 3 trials (Observational 3) 2011: 1 trials (Observational 1) 2012: 4 trials (Observational 4) 2013: 2 trials (Observational 1, Not applicable 1) 2014: 4 trials (Observational 4) 2015: 4 trials (Observational 4) 2016: 1 trials (Not applicable 1) 2017: 1 trials (Observational 1) 2018: 1 trials (Observational 1) 2020: 1 trials (Observational 1) 2021: 1 trials (Observational 1) 2025: 1 trials (Observational 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 2
2025 1
2021 1
2020 1
2018 1
2017 1
2016 1
2015 4
2014 4
2013 2

No forecast is made for this condition: it averages 0.6 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: none of the 27 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Trisomy 18 Syndrome trials in? (2)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Not applicable 2
Observational 25

How many Trisomy 18 Syndrome trials are recruiting? (6)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 1
Recruiting 1
Active, not recruiting 1
Completed 17
Terminated 2

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Trisomy 18 Syndrome trials? (10)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
Natera, Inc. 8
Sequenom, Inc. 4
Progenity, Inc. 3
Azienda Usl di Bologna 1
BillionToOne Inc. 1

Interventions as named in the registry (1)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
BLOOD SAMPLE 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which publications cover Trisomy 18 Syndrome? (10)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Prevalence (50)

Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.

Prevalence
Orphanet disease Type Class Geography Jurisdiction Mapping relation
Trisomy 18 syndrome Prevalence at birth 1-5 / 10 000 United Kingdom GB Exact
Trisomy 18 syndrome Prevalence at birth 1-5 / 10 000 United Kingdom GB Exact
Trisomy 18 syndrome Prevalence at birth 1-5 / 10 000 United States US Exact
Trisomy 18 syndrome Prevalence at birth 1-5 / 10 000 United States US Exact
Trisomy 18 syndrome Prevalence at birth 1-5 / 10 000 Denmark Not stated Exact

Rare-disease identity (2)

Shown in this order: exact, broader, narrower, other.

Rare-disease identity
Orphanet disease ORPHA code Relation Source
Trisomy 18 syndrome 3380 Exact Orphanet Rare Disease Ontology (ORDO)
Trisomy 18 syndrome 3380 Exact Orphadata Science knowledge files, Product 1

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: serious adverse events in this condition's trials and sub-conditions in mesh.

Browse all condition evidence pages